> top > docs > PMC:3320587 > spans > 41009-41911 > annotations

PMC:3320587 / 41009-41911 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T15245 900-901 -RRB- denotes )
T15244 898-900 NN denotes 7A
T15243 891-897 NN denotes Figure
T15242 890-891 -LRB- denotes (
T15241 879-889 NN denotes expression
T15240 874-878 NN denotes gene
T15239 868-873 NN denotes NFAT5
T15238 865-867 IN denotes on
T15237 858-864 NN denotes effect
T15236 846-857 JJ denotes stimulatory
T15235 842-845 PRP-DOLLAR- denotes its
T15234 831-841 VB denotes augmenting
T15233 829-830 -COMMA- denotes ,
T15232 820-829 NN denotes infection
T15231 816-819 NN denotes MTb
T15230 809-815 JJ denotes actual
T15229 802-808 IN denotes during
T15228 792-801 VB denotes triggered
T15227 789-791 VB denotes be
T15226 785-788 MD denotes may
T15225 780-784 NN denotes PRRs
T15224 769-779 JJ denotes additional
T15223 764-768 IN denotes that
T15222 753-763 VB denotes suggesting
T15221 751-752 -COMMA- denotes ,
T15220 740-751 NN denotes stimulation
T15219 732-739 NN denotes Pam3Cys
T15218 727-731 IN denotes than
T15217 720-726 NN denotes extent
T15216 712-719 JJ denotes greater
T15215 710-711 DT denotes a
T15214 707-709 TO denotes to
T15213 700-706 NN denotes levels
T15212 695-699 NN denotes mRNA
T15211 689-694 NN denotes NFAT5
T15210 680-688 VB denotes enhanced
T15209 670-679 NN denotes infection
T15208 666-669 NN denotes MTb
T15207 664-665 -COMMA- denotes ,
T15206 657-664 RB denotes Notably
T15205 654-655 -RRB- denotes )
T15204 652-654 NN denotes 7A
T15203 645-651 NN denotes Figure
T15202 644-645 -LRB- denotes (
T15201 636-643 NN denotes CDC1551
T15200 631-635 IN denotes with
T15199 625-630 NN denotes cells
T15198 619-624 NN denotes THP-1
T15197 610-618 VB denotes infected
T15196 605-609 RB denotes also
T15195 602-604 PRP denotes we
T15194 591-601 NN denotes experiment
T15193 586-590 DT denotes this
T15192 582-585 IN denotes for
T15191 574-581 NN denotes control
T15190 565-573 JJ denotes positive
T15189 563-564 DT denotes a
T15188 560-562 IN denotes As
T15187 557-558 -RRB- denotes )
T15186 555-557 NN denotes 7A
T15185 548-554 NN denotes Figure
T15184 547-548 -LRB- denotes (
T15183 541-546 NN denotes cells
T15182 533-540 NN denotes control
T15181 517-532 JJ denotes mock-stimulated
T15180 514-516 TO denotes to
T15179 505-513 VB denotes compared
T15178 502-504 IN denotes as
T15177 496-501 NN denotes cells
T15176 477-495 JJ denotes Pam3Cys-stimulated
T15175 474-476 IN denotes in
T15174 464-473 VB denotes increased
T15173 450-463 RB denotes significantly
T15172 445-449 VB denotes were
T15171 438-444 NN denotes levels
T15170 433-437 NN denotes mRNA
T15169 427-432 NN denotes NFAT5
T15168 425-426 -COMMA- denotes ,
T15167 420-425 NN denotes hours
T15166 417-419 CD denotes 16
T15165 413-416 IN denotes for
T15164 405-412 NN denotes Pam3Cys
T15163 397-404 NN denotes agonist
T15162 383-396 JJ denotes TLR2-specific
T15161 379-382 DT denotes the
T15160 374-378 IN denotes with
T15159 366-373 VB denotes treated
T15158 361-365 VB denotes were
T15157 355-360 NN denotes cells
T15156 349-354 NN denotes THP-1
T15155 344-348 WRB denotes When
T15154 336-342 NN denotes levels
T15153 331-335 NN denotes mRNA
T15152 325-330 NN denotes NFAT5
T15151 315-324 VB denotes enhancing
T15150 312-314 IN denotes in
T15149 303-311 NN denotes ligation
T15148 298-302 NN denotes TLR2
T15147 295-297 IN denotes of
T15146 283-294 NN denotes requirement
T15145 279-282 DT denotes the
T15144 269-278 VB denotes examining
T15143 266-268 IN denotes by
T15142 260-265 VB denotes began
T15141 257-259 PRP denotes We
T15140 245-255 NN denotes expression
T15139 240-244 NN denotes gene
T15138 234-239 NN denotes NFAT5
T15137 231-233 IN denotes of
T15136 219-230 NN denotes stimulation
T15135 215-218 NN denotes MTb
T15134 211-214 IN denotes for
T15133 202-210 VB denotes required
T15132 198-201 VB denotes are
T15131 193-197 WDT denotes that
T15130 185-192 NN denotes pathway
T15129 181-184 NN denotes TLR
T15128 177-180 DT denotes the
T15127 174-176 IN denotes in
T15126 164-173 NN denotes molecules
T15125 154-163 VB denotes signaling
T15124 145-153 JJ denotes specific
T15123 141-144 IN denotes for
T15122 129-140 NN denotes requirement
T15121 125-128 DT denotes the
T15120 112-124 VB denotes investigated
T15119 107-111 RB denotes next
T15118 104-106 PRP denotes we
T15117 102-103 -COMMA- denotes ,
T15116 91-102 NN denotes replication
T15115 85-90 NN denotes HIV-1
T15114 73-84 JJ denotes MTb-induced
T15113 71-72 -COMMA- denotes ,
T15112 56-71 JJ denotes NFAT5-dependent
T15111 45-55 VB denotes underlying
T15110 34-44 NN denotes mechanisms
T15109 25-33 JJ denotes cellular
T15108 21-24 DT denotes the
T15107 12-20 VB denotes decipher
T15106 9-11 TO denotes to
T15105 3-8 VB denotes begin
T15104 0-2 TO denotes To
R10992 T15105 T15104 arg1Of begin,To
R10993 T15107 T15105 arg2Of decipher,begin
R10994 T15107 T15106 arg1Of decipher,to
R10995 T15110 T15107 arg2Of mechanisms,decipher
R10996 T15110 T15108 arg1Of mechanisms,the
R10997 T15110 T15109 arg1Of mechanisms,cellular
R10998 T15110 T15111 arg1Of mechanisms,underlying
R10999 T15112 T15113 arg1Of NFAT5-dependent,","
R11000 T15114 T15113 arg2Of MTb-induced,","
R11001 T15116 T15111 arg2Of replication,underlying
R11002 T15116 T15112 arg1Of replication,NFAT5-dependent
R11003 T15116 T15114 arg1Of replication,MTb-induced
R11004 T15116 T15115 arg1Of replication,HIV-1
R11005 T15118 T15105 arg1Of we,begin
R11006 T15118 T15107 arg1Of we,decipher
R11007 T15118 T15120 arg1Of we,investigated
R11008 T15120 T15104 modOf investigated,To
R11009 T15120 T15117 arg1Of investigated,","
R11010 T15120 T15119 arg1Of investigated,next
R11011 T15122 T15120 arg2Of requirement,investigated
R11012 T15122 T15121 arg1Of requirement,the
R11013 T15122 T15123 arg1Of requirement,for
R11014 T15126 T15123 arg2Of molecules,for
R11015 T15126 T15124 arg1Of molecules,specific
R11016 T15126 T15125 arg1Of molecules,signaling
R11017 T15126 T15127 arg1Of molecules,in
R11018 T15126 T15131 arg1Of molecules,that
R11019 T15126 T15132 arg1Of molecules,are
R11020 T15126 T15133 arg2Of molecules,required
R11021 T15130 T15127 arg2Of pathway,in
R11022 T15130 T15128 arg1Of pathway,the
R11023 T15130 T15129 arg1Of pathway,TLR
R11024 T15133 T15132 arg2Of required,are
R11025 T15133 T15134 arg1Of required,for
R11026 T15136 T15134 arg2Of stimulation,for
R11027 T15136 T15135 arg1Of stimulation,MTb
R11028 T15136 T15137 arg1Of stimulation,of
R11029 T15140 T15137 arg2Of expression,of
R11030 T15140 T15138 arg1Of expression,NFAT5
R11031 T15140 T15139 arg1Of expression,gene
R11032 T15141 T15142 arg1Of We,began
R11033 T15141 T15144 arg1Of We,examining
R11034 T15142 T15143 arg1Of began,by
R11035 T15144 T15143 arg2Of examining,by
R11036 T15146 T15144 arg2Of requirement,examining
R11037 T15146 T15145 arg1Of requirement,the
R11038 T15146 T15147 arg1Of requirement,of
R11039 T15146 T15150 arg1Of requirement,in
R11040 T15149 T15147 arg2Of ligation,of
R11041 T15149 T15148 arg1Of ligation,TLR2
R11042 T15151 T15150 arg2Of enhancing,in
R11043 T15154 T15151 arg2Of levels,enhancing
R11044 T15154 T15152 arg1Of levels,NFAT5
R11045 T15154 T15153 arg1Of levels,mRNA
R11046 T15157 T15156 arg1Of cells,THP-1
R11047 T15157 T15158 arg1Of cells,were
R11048 T15157 T15159 arg2Of cells,treated
R11049 T15159 T15155 arg2Of treated,When
R11050 T15159 T15158 arg2Of treated,were
R11051 T15159 T15160 arg1Of treated,with
R11052 T15164 T15160 arg2Of Pam3Cys,with
R11053 T15164 T15161 arg1Of Pam3Cys,the
R11054 T15164 T15162 arg1Of Pam3Cys,TLR2-specific
R11055 T15164 T15163 arg1Of Pam3Cys,agonist
R11056 T15164 T15165 arg1Of Pam3Cys,for
R11057 T15167 T15165 arg2Of hours,for
R11058 T15167 T15166 arg1Of hours,16
R11059 T15171 T15169 arg1Of levels,NFAT5
R11060 T15171 T15170 arg1Of levels,mRNA
R11061 T15171 T15172 arg1Of levels,were
R11062 T15171 T15174 arg2Of levels,increased
R11063 T15174 T15155 arg1Of increased,When
R11064 T15174 T15168 arg1Of increased,","
R11065 T15174 T15172 arg2Of increased,were
R11066 T15174 T15173 arg1Of increased,significantly
R11067 T15174 T15175 arg1Of increased,in
R11068 T15174 T15178 arg1Of increased,as
R11069 T15177 T15175 arg2Of cells,in
R11070 T15177 T15176 arg1Of cells,Pam3Cys-stimulated
R11071 T15179 T15178 arg2Of compared,as
R11072 T15179 T15180 arg1Of compared,to
R11073 T15183 T15180 arg2Of cells,to
R11074 T15183 T15181 arg1Of cells,mock-stimulated
R11075 T15183 T15182 arg1Of cells,control
R11076 T15183 T15184 arg1Of cells,(
R11077 T15186 T15184 arg2Of 7A,(
R11078 T15186 T15185 arg1Of 7A,Figure
R11079 T15187 T15184 arg3Of ),(
R11080 T15191 T15188 arg2Of control,As
R11081 T15191 T15189 arg1Of control,a
R11082 T15191 T15190 arg1Of control,positive
R11083 T15191 T15192 arg1Of control,for
R11084 T15194 T15192 arg2Of experiment,for
R11085 T15194 T15193 arg1Of experiment,this
R11086 T15195 T15197 arg1Of we,infected
R11087 T15197 T15188 arg1Of infected,As
R11088 T15197 T15196 arg1Of infected,also
R11089 T15197 T15200 arg1Of infected,with
R11090 T15199 T15197 arg2Of cells,infected
R11091 T15199 T15198 arg1Of cells,THP-1
R11092 T15201 T15200 arg2Of CDC1551,with
R11093 T15201 T15202 arg1Of CDC1551,(
R11094 T15204 T15202 arg2Of 7A,(
R11095 T15204 T15203 arg1Of 7A,Figure
R11096 T15205 T15202 arg3Of ),(
R11097 T15209 T15208 arg1Of infection,MTb
R11098 T15209 T15210 arg1Of infection,enhanced
R11099 T15209 T15234 arg1Of infection,augmenting
R11100 T15210 T15206 arg1Of enhanced,Notably
R11101 T15210 T15207 arg1Of enhanced,","
R11102 T15210 T15214 arg1Of enhanced,to
R11103 T15210 T15221 arg1Of enhanced,","
R11104 T15210 T15233 arg1Of enhanced,","
R11105 T15210 T15234 modOf enhanced,augmenting
R11106 T15213 T15210 arg2Of levels,enhanced
R11107 T15213 T15211 arg1Of levels,NFAT5
R11108 T15213 T15212 arg1Of levels,mRNA
R11109 T15217 T15214 arg2Of extent,to
R11110 T15217 T15215 arg1Of extent,a
R11111 T15217 T15216 arg1Of extent,greater
R11112 T15217 T15218 arg1Of extent,than
R11113 T15220 T15218 arg2Of stimulation,than
R11114 T15220 T15219 arg1Of stimulation,Pam3Cys
R11115 T15222 T15210 arg3Of suggesting,enhanced
R11116 T15225 T15224 arg1Of PRRs,additional
R11117 T15225 T15226 arg1Of PRRs,may
R11118 T15225 T15227 arg1Of PRRs,be
R11119 T15225 T15228 arg2Of PRRs,triggered
R11120 T15228 T15222 arg2Of triggered,suggesting
R11121 T15228 T15223 arg1Of triggered,that
R11122 T15228 T15226 arg2Of triggered,may
R11123 T15228 T15227 arg2Of triggered,be
R11124 T15228 T15229 arg1Of triggered,during
R11125 T15232 T15229 arg2Of infection,during
R11126 T15232 T15230 arg1Of infection,actual
R11127 T15232 T15231 arg1Of infection,MTb
R11128 T15237 T15234 arg2Of effect,augmenting
R11129 T15237 T15235 arg1Of effect,its
R11130 T15237 T15236 arg1Of effect,stimulatory
R11131 T15237 T15238 arg1Of effect,on
R11132 T15241 T15238 arg2Of expression,on
R11133 T15241 T15239 arg1Of expression,NFAT5
R11134 T15241 T15240 arg1Of expression,gene
R11135 T15241 T15242 arg1Of expression,(
R11136 T15244 T15242 arg2Of 7A,(
R11137 T15244 T15243 arg1Of 7A,Figure
R11138 T15245 T15242 arg3Of ),(

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T14913 868-873 Protein denotes NFAT5
T14912 689-694 Protein denotes NFAT5
T14911 427-432 Protein denotes NFAT5
T14910 383-387 Protein denotes TLR2
T14909 325-330 Protein denotes NFAT5
T14908 298-302 Protein denotes TLR2
T14907 234-239 Protein denotes NFAT5
T14906 56-61 Protein denotes NFAT5

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T15610 868-873 http://www.uniprot.org/uniprot/O94916 denotes NFAT5
T15609 689-694 http://www.uniprot.org/uniprot/O94916 denotes NFAT5
T15608 427-432 http://www.uniprot.org/uniprot/O94916 denotes NFAT5
T15607 325-330 http://www.uniprot.org/uniprot/O94916 denotes NFAT5
T15606 234-239 http://www.uniprot.org/uniprot/O94916 denotes NFAT5
T15605 56-61 http://www.uniprot.org/uniprot/O94916 denotes NFAT5
T15633 383-387 http://www.uniprot.org/uniprot/O60603 denotes TLR2
T15632 298-302 http://www.uniprot.org/uniprot/O60603 denotes TLR2

GO-BP

Id Subject Object Predicate Lexical cue
T14972 25-33 http://purl.obolibrary.org/obo/GO_0007349 denotes cellular
T14969 154-163 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T14961 874-889 http://purl.obolibrary.org/obo/GO_0010467 denotes gene expression
T14960 240-255 http://purl.obolibrary.org/obo/GO_0010467 denotes gene expression

GO-CC

Id Subject Object Predicate Lexical cue
T14978 625-630 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T14977 541-546 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T14976 496-501 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T14975 355-360 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

sentences

Id Subject Object Predicate Lexical cue
T14771 657-902 Sentence denotes Notably, MTb infection enhanced NFAT5 mRNA levels to a greater extent than Pam3Cys stimulation, suggesting that additional PRRs may be triggered during actual MTb infection, augmenting its stimulatory effect on NFAT5 gene expression (Figure 7A).
T14770 560-656 Sentence denotes As a positive control for this experiment we also infected THP-1 cells with CDC1551 (Figure 7A).
T14769 344-559 Sentence denotes When THP-1 cells were treated with the TLR2-specific agonist Pam3Cys for 16 hours, NFAT5 mRNA levels were significantly increased in Pam3Cys-stimulated cells as compared to mock-stimulated control cells (Figure 7A).
T14768 257-343 Sentence denotes We began by examining the requirement of TLR2 ligation in enhancing NFAT5 mRNA levels.
T14767 0-256 Sentence denotes To begin to decipher the cellular mechanisms underlying NFAT5-dependent, MTb-induced HIV-1 replication, we next investigated the requirement for specific signaling molecules in the TLR pathway that are required for MTb stimulation of NFAT5 gene expression.
T240 0-256 Sentence denotes To begin to decipher the cellular mechanisms underlying NFAT5-dependent, MTb-induced HIV-1 replication, we next investigated the requirement for specific signaling molecules in the TLR pathway that are required for MTb stimulation of NFAT5 gene expression.
T241 257-343 Sentence denotes We began by examining the requirement of TLR2 ligation in enhancing NFAT5 mRNA levels.
T242 344-559 Sentence denotes When THP-1 cells were treated with the TLR2-specific agonist Pam3Cys for 16 hours, NFAT5 mRNA levels were significantly increased in Pam3Cys-stimulated cells as compared to mock-stimulated control cells (Figure 7A).
T243 560-656 Sentence denotes As a positive control for this experiment we also infected THP-1 cells with CDC1551 (Figure 7A).
T244 657-902 Sentence denotes Notably, MTb infection enhanced NFAT5 mRNA levels to a greater extent than Pam3Cys stimulation, suggesting that additional PRRs may be triggered during actual MTb infection, augmenting its stimulatory effect on NFAT5 gene expression (Figure 7A).

simple1

Id Subject Object Predicate Lexical cue
T14993 868-873 Protein denotes NFAT5
T14992 689-694 Protein denotes NFAT5
T14991 427-432 Protein denotes NFAT5
T14990 383-387 Protein denotes TLR2
T14989 325-330 Protein denotes NFAT5
T14988 298-302 Protein denotes TLR2
T14987 234-239 Protein denotes NFAT5
T14986 56-61 Protein denotes NFAT5

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T16752 879-889 Gene_expression denotes expression
T16751 831-841 Positive_regulation denotes augmenting
T16750 700-706 Transcription denotes levels
T16749 858-864 Regulation denotes effect
T16748 680-688 Positive_regulation denotes enhanced
T16747 438-444 Transcription denotes levels
T16746 464-473 Positive_regulation denotes increased
T16745 315-324 Positive_regulation denotes enhancing
T16744 336-342 Transcription denotes levels
T16743 283-294 Positive_regulation denotes requirement
T16742 303-311 Binding denotes ligation
T16741 245-255 Gene_expression denotes expression
T16693 689-694 Protein denotes NFAT5
T16692 868-873 Protein denotes NFAT5
T16691 427-432 Protein denotes NFAT5
T16690 383-387 Protein denotes TLR2
T16689 325-330 Protein denotes NFAT5
T16688 298-302 Protein denotes TLR2
T16687 234-239 Protein denotes NFAT5
T16686 56-61 Protein denotes NFAT5
R12364 T16687 T16741 themeOf NFAT5,expression
R12365 T16688 T16742 themeOf TLR2,ligation
R12366 T16689 T16745 themeOf NFAT5,enhancing
R12367 T16689 T16744 themeOf NFAT5,levels
R12368 T16691 T16747 themeOf NFAT5,levels
R12369 T16691 T16746 themeOf NFAT5,increased
R12370 T16692 T16752 themeOf NFAT5,expression
R12371 T16693 T16748 themeOf NFAT5,enhanced
R12372 T16693 T16750 themeOf NFAT5,levels
R12415 T16745 T16743 themeOf enhancing,requirement
R12416 T16749 T16751 themeOf effect,augmenting
R12417 T16752 T16749 themeOf expression,effect

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T15830 858-864 Regulation denotes effect
T15829 680-688 Positive_regulation denotes enhanced
T15828 879-889 Gene_expression denotes expression
T15827 464-473 Positive_regulation denotes increased
T15826 315-324 Positive_regulation denotes enhancing
T15825 303-311 Binding denotes ligation
T15824 245-255 Gene_expression denotes expression
T15776 689-694 Protein denotes NFAT5
T15775 868-873 Protein denotes NFAT5
T15774 427-432 Protein denotes NFAT5
T15773 383-387 Protein denotes TLR2
T15772 325-330 Protein denotes NFAT5
T15771 298-302 Protein denotes TLR2
T15770 234-239 Protein denotes NFAT5
T15769 56-61 Protein denotes NFAT5
R11604 T15770 T15824 themeOf NFAT5,expression
R11605 T15771 T15825 themeOf TLR2,ligation
R11606 T15772 T15826 themeOf NFAT5,enhancing
R11607 T15774 T15827 themeOf NFAT5,increased
R11608 T15775 T15828 themeOf NFAT5,expression
R11609 T15776 T15829 themeOf NFAT5,enhanced
R11646 T15828 T15830 themeOf expression,effect

DLUT931

Id Subject Object Predicate Lexical cue
T15716 464-473 Positive_regulation denotes increased
T15715 438-444 Transcription denotes levels
T15714 315-324 Positive_regulation denotes enhancing
T15713 283-294 Positive_regulation denotes requirement
T15712 336-342 Transcription denotes levels
T15711 303-311 Binding denotes ligation
T15710 202-210 Positive_regulation denotes required
T15709 245-255 Gene_expression denotes expression
T15661 689-694 Protein denotes NFAT5
T15660 868-873 Protein denotes NFAT5
T15659 427-432 Protein denotes NFAT5
T15658 383-387 Protein denotes TLR2
T15657 325-330 Protein denotes NFAT5
T15656 298-302 Protein denotes TLR2
T15655 234-239 Protein denotes NFAT5
T15654 56-61 Protein denotes NFAT5
T15720 858-864 Regulation denotes effect
T15719 680-688 Positive_regulation denotes enhanced
T15718 879-889 Gene_expression denotes expression
T15717 700-706 Transcription denotes levels
R11503 T15656 T15711 themeOf TLR2,ligation
R11504 T15657 T15712 themeOf NFAT5,levels
R11505 T15659 T15715 themeOf NFAT5,levels
R11506 T15660 T15718 themeOf NFAT5,expression
R11507 T15661 T15717 themeOf NFAT5,levels
R11552 T15709 T15710 themeOf expression,required
R11553 T15711 T15713 themeOf ligation,requirement
R11554 T15712 T15714 themeOf levels,enhancing
R11555 T15714 T15713 themeOf enhancing,requirement
R11556 T15715 T15716 themeOf levels,increased
R11557 T15717 T15719 themeOf levels,enhanced
R11558 T15718 T15720 themeOf expression,effect
R11502 T15655 T15709 themeOf NFAT5,expression

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue Speculation
T16915 865-901 Gene_expression denotes on NFAT5 gene expression (Figure 7A)
T16914 764-829 Positive_regulation denotes that additional PRRs may be triggered during actual MTb infection true
T16912 666-679 Regulation denotes MTb infection
T16904 231-255 Gene_expression denotes of NFAT5 gene expression
T16903 215-255 Positive_regulation denotes MTb stimulation of NFAT5 gene expression
T16902 809-829 Regulation denotes actual MTb infection
T16900 514-540 Positive_regulation denotes to mock-stimulated control
T16889 325-330 Protein denotes NFAT5
T16883 427-432 Protein denotes NFAT5
T16882 666-669 Protein denotes MTb
T16879 325-342 Protein denotes NFAT5 mRNA levels
T16874 73-84 Protein denotes MTb-induced
T16873 21-102 Protein denotes the cellular mechanisms underlying NFAT5-dependent, MTb-induced HIV-1 replication
T16860 234-239 Protein denotes NFAT5
T16859 397-404 Entity denotes agonist
T16858 298-302 Protein denotes TLR2
T16847 164-173 Entity denotes molecules
T16843 689-706 Protein denotes NFAT5 mRNA levels
T16838 695-699 Protein denotes mRNA
T16835 769-784 Protein denotes additional PRRs
T16831 477-480 Protein denotes Pam
T16825 868-873 Protein denotes NFAT5
T16819 215-218 Protein denotes MTb
T16816 816-819 Protein denotes MTb
T16811 379-396 Protein denotes the TLR2-specific
T16795 541-558 Entity denotes cells (Figure 7A)
R12433 T16816 T16902 themeOf MTb,actual MTb infection
R12435 T16819 T16903 causeOf MTb,MTb stimulation of NFAT5 gene expression
R12437 T16825 T16915 themeOf NFAT5,on NFAT5 gene expression (Figure 7A)
R12441 T16835 T16914 themeOf additional PRRs,that additional PRRs may be triggered during actual MTb infection
R12449 T16860 T16904 themeOf NFAT5,of NFAT5 gene expression
R12455 T16882 T16912 themeOf MTb,MTb infection
R12460 T16904 T16903 themeOf of NFAT5 gene expression,MTb stimulation of NFAT5 gene expression

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T16309 901-902 . denotes .
T16308 900-901 -RRB- denotes )
T16307 898-900 NN denotes 7A
T16306 891-897 NN denotes Figure
T16305 890-891 -LRB- denotes (
T16304 879-889 NN denotes expression
T16303 874-878 NN denotes gene
T16215 342-343 . denotes .
T16214 336-342 NNS denotes levels
T16213 331-335 NNP denotes mRNA
T16212 325-330 NNP denotes NFAT5
T16211 315-324 VBG denotes enhancing
T16210 312-314 IN denotes in
T16209 303-311 NN denotes ligation
T16208 298-302 CD denotes TLR2
T16207 295-297 IN denotes of
T16206 283-294 NN denotes requirement
T16205 279-282 DT denotes the
T16204 269-278 VBG denotes examining
T16203 266-268 IN denotes by
T16202 260-265 VBD denotes began
T16201 257-259 PRP denotes We
T16200 255-256 . denotes .
T16199 245-255 NN denotes expression
T16198 240-244 NN denotes gene
T16197 234-239 CD denotes NFAT5
T16196 231-233 IN denotes of
T16195 219-230 NN denotes stimulation
T16194 215-218 NNP denotes MTb
T16193 211-214 IN denotes for
T16192 202-210 VBN denotes required
T16191 198-201 VBP denotes are
T16190 193-197 WDT denotes that
T16189 185-192 NN denotes pathway
T16188 181-184 NNP denotes TLR
T16187 177-180 DT denotes the
T16186 174-176 IN denotes in
T16185 164-173 NNS denotes molecules
T16184 154-163 VBG denotes signaling
T16183 145-153 JJ denotes specific
T16182 141-144 IN denotes for
T16181 129-140 NN denotes requirement
T16180 125-128 DT denotes the
T16179 112-124 VBD denotes investigated
T16178 107-111 JJ denotes next
T16177 104-106 PRP denotes we
T16176 102-103 , denotes ,
T16175 91-102 NN denotes replication
T16174 85-90 NN denotes HIV-1
T16173 73-84 JJ denotes MTb-induced
T16172 71-72 , denotes ,
T16171 56-71 JJ denotes NFAT5-dependent
T16170 45-55 VBG denotes underlying
T16169 34-44 NNS denotes mechanisms
T16168 25-33 JJ denotes cellular
T16167 21-24 DT denotes the
T16166 12-20 VB denotes decipher
T16165 9-11 TO denotes to
T16164 3-8 VB denotes begin
T16163 0-2 TO denotes To
T16274 689-694 NNP denotes NFAT5
T16273 680-688 VBN denotes enhanced
T16257 602-604 PRP denotes we
T16256 591-601 NN denotes experiment
T16255 586-590 DT denotes this
T16254 582-585 IN denotes for
T16253 574-581 NN denotes control
T16252 565-573 JJ denotes positive
T16251 563-564 DT denotes a
T16250 560-562 IN denotes As
T16249 558-559 . denotes .
T16248 557-558 -RRB- denotes )
T16247 555-557 NN denotes 7A
T16246 548-554 NN denotes Figure
T16245 547-548 -LRB- denotes (
T16244 541-546 NNS denotes cells
T16243 533-540 NN denotes control
T16242 517-532 JJ denotes mock-stimulated
T16241 514-516 TO denotes to
T16240 505-513 VBN denotes compared
T16239 502-504 IN denotes as
T16238 496-501 NNS denotes cells
T16237 477-495 JJ denotes Pam3Cys-stimulated
T16236 474-476 IN denotes in
T16235 464-473 VBN denotes increased
T16234 450-463 RB denotes significantly
T16233 445-449 VBD denotes were
T16232 438-444 NNS denotes levels
T16231 433-437 NNP denotes mRNA
T16230 427-432 NNP denotes NFAT5
T16229 425-426 , denotes ,
T16228 420-425 NNS denotes hours
T16227 417-419 CD denotes 16
T16226 413-416 IN denotes for
T16225 405-412 NNS denotes Pam3Cys
T16224 397-404 NN denotes agonist
T16223 383-396 JJ denotes TLR2-specific
T16222 379-382 DT denotes the
T16221 374-378 IN denotes with
T16220 366-373 VBN denotes treated
T16219 361-365 VBD denotes were
T16218 355-360 NNS denotes cells
T16217 349-354 JJ denotes THP-1
T16216 344-348 WRB denotes When
T16302 868-873 CD denotes NFAT5
T16301 865-867 IN denotes on
T16300 858-864 NN denotes effect
T16299 846-857 JJ denotes stimulatory
T16298 842-845 PRP$ denotes its
T16297 831-841 VBG denotes augmenting
T16296 829-830 , denotes ,
T16295 820-829 NN denotes infection
T16294 816-819 NNP denotes MTb
T16293 809-815 JJ denotes actual
T16292 802-808 IN denotes during
T16291 792-801 VBN denotes triggered
T16290 789-791 VB denotes be
T16289 785-788 MD denotes may
T16288 780-784 NNS denotes PRRs
T16287 769-779 JJ denotes additional
T16286 764-768 IN denotes that
T16285 753-763 VBG denotes suggesting
T16284 751-752 , denotes ,
T16283 740-751 NN denotes stimulation
T16282 732-739 NNS denotes Pam3Cys
T16281 727-731 IN denotes than
T16280 720-726 NN denotes extent
T16279 712-719 JJR denotes greater
T16278 710-711 DT denotes a
T16277 707-709 TO denotes to
T16276 700-706 NNS denotes levels
T16275 695-699 NNP denotes mRNA
T16272 670-679 NN denotes infection
T16271 666-669 NNP denotes MTb
T16270 664-665 , denotes ,
T16269 657-664 RB denotes Notably
T16268 655-656 . denotes .
T16267 654-655 -RRB- denotes )
T16266 652-654 NN denotes 7A
T16265 645-651 NNP denotes Figure
T16264 644-645 -LRB- denotes (
T16263 636-643 NNP denotes CDC1551
T16262 631-635 IN denotes with
T16261 625-630 NNS denotes cells
T16260 619-624 CD denotes THP-1
T16259 610-618 VBD denotes infected
T16258 605-609 RB denotes also
R11842 T16163 T16164 aux To,begin
R11844 T16165 T16166 aux to,decipher
R11845 T16166 T16164 xcomp decipher,begin
R11846 T16167 T16169 det the,mechanisms
R11847 T16168 T16169 amod cellular,mechanisms
R11881 T16202 T16202 ROOT began,began
R11882 T16203 T16202 prep by,began
R11889 T16210 T16204 prep in,examining
R11891 T16212 T16213 compound NFAT5,mRNA
R11892 T16213 T16214 compound mRNA,levels
R11893 T16214 T16211 dobj levels,enhancing
R11894 T16215 T16202 punct .,began
R11895 T16216 T16220 advmod When,treated
R11896 T16217 T16218 amod THP-1,cells
R11897 T16218 T16220 nsubjpass cells,treated
R11898 T16219 T16220 auxpass were,treated
R11899 T16220 T16235 advcl treated,increased
R11900 T16221 T16220 prep with,treated
R11901 T16222 T16225 det the,Pam3Cys
R11902 T16223 T16225 amod TLR2-specific,Pam3Cys
R11903 T16224 T16225 compound agonist,Pam3Cys
R11904 T16225 T16221 pobj Pam3Cys,with
R11905 T16226 T16220 prep for,treated
R11906 T16227 T16228 nummod 16,hours
R11907 T16228 T16226 pobj hours,for
R11908 T16229 T16235 punct ",",increased
R11909 T16230 T16232 compound NFAT5,levels
R11910 T16231 T16232 compound mRNA,levels
R11911 T16232 T16235 nsubjpass levels,increased
R11912 T16233 T16235 auxpass were,increased
R11913 T16234 T16235 advmod significantly,increased
R11914 T16235 T16235 ROOT increased,increased
R11915 T16236 T16235 prep in,increased
R11916 T16237 T16238 amod Pam3Cys-stimulated,cells
R11917 T16238 T16236 pobj cells,in
R11918 T16239 T16235 prep as,increased
R11919 T16240 T16235 prep compared,increased
R11920 T16241 T16240 prep to,compared
R11921 T16242 T16244 amod mock-stimulated,cells
R11922 T16243 T16244 compound control,cells
R11923 T16244 T16241 pobj cells,to
R11924 T16245 T16247 punct (,7A
R11925 T16246 T16247 compound Figure,7A
R11926 T16247 T16244 appos 7A,cells
R11927 T16248 T16244 punct ),cells
R11928 T16249 T16235 punct .,increased
R11929 T16250 T16259 prep As,infected
R11930 T16251 T16253 det a,control
R11931 T16252 T16253 amod positive,control
R11932 T16253 T16250 pobj control,As
R11933 T16254 T16253 prep for,control
R11934 T16255 T16256 det this,experiment
R11935 T16256 T16254 pobj experiment,for
R11936 T16257 T16259 nsubj we,infected
R11937 T16258 T16259 advmod also,infected
R11938 T16259 T16259 ROOT infected,infected
R11939 T16260 T16261 nummod THP-1,cells
R11940 T16261 T16259 dobj cells,infected
R11941 T16262 T16259 prep with,infected
R11942 T16263 T16262 pobj CDC1551,with
R11943 T16264 T16266 punct (,7A
R11944 T16265 T16266 compound Figure,7A
R11945 T16266 T16263 appos 7A,CDC1551
R11946 T16267 T16266 punct ),7A
R11947 T16268 T16259 punct .,infected
R11948 T16269 T16273 advmod Notably,enhanced
R11949 T16270 T16273 punct ",",enhanced
R11950 T16271 T16272 compound MTb,infection
R11951 T16272 T16273 nsubj infection,enhanced
R11952 T16273 T16273 ROOT enhanced,enhanced
R11953 T16274 T16275 compound NFAT5,mRNA
R11954 T16275 T16276 compound mRNA,levels
R11955 T16276 T16273 dobj levels,enhanced
R11956 T16277 T16276 prep to,levels
R11957 T16278 T16280 det a,extent
R11958 T16279 T16280 amod greater,extent
R11959 T16280 T16277 pobj extent,to
R11960 T16281 T16276 prep than,levels
R11961 T16282 T16283 compound Pam3Cys,stimulation
R11962 T16283 T16281 pobj stimulation,than
R11963 T16284 T16273 punct ",",enhanced
R11964 T16285 T16273 advcl suggesting,enhanced
R11965 T16286 T16291 mark that,triggered
R11966 T16287 T16288 amod additional,PRRs
R11967 T16288 T16291 nsubjpass PRRs,triggered
R11968 T16289 T16291 aux may,triggered
R11969 T16290 T16291 auxpass be,triggered
R11970 T16291 T16285 ccomp triggered,suggesting
R11971 T16292 T16291 prep during,triggered
R11972 T16293 T16295 amod actual,infection
R11973 T16294 T16295 compound MTb,infection
R11974 T16295 T16292 pobj infection,during
R11975 T16296 T16291 punct ",",triggered
R11976 T16297 T16291 advcl augmenting,triggered
R11977 T16298 T16300 poss its,effect
R11978 T16299 T16300 amod stimulatory,effect
R11979 T16300 T16297 dobj effect,augmenting
R11980 T16301 T16300 prep on,effect
R11981 T16302 T16304 nummod NFAT5,expression
R11982 T16303 T16304 compound gene,expression
R11983 T16304 T16301 pobj expression,on
R11984 T16305 T16307 punct (,7A
R11985 T16306 T16307 compound Figure,7A
R11986 T16307 T16304 appos 7A,expression
R11987 T16308 T16307 punct ),7A
R11988 T16309 T16273 punct .,enhanced
R11848 T16169 T16166 dobj mechanisms,decipher
R11849 T16170 T16169 acl underlying,mechanisms
R11850 T16171 T16175 amod NFAT5-dependent,replication
R11851 T16172 T16175 punct ",",replication
R11852 T16173 T16175 amod MTb-induced,replication
R11853 T16174 T16175 compound HIV-1,replication
R11854 T16175 T16170 dobj replication,underlying
R11855 T16176 T16179 punct ",",investigated
R11856 T16177 T16179 nsubj we,investigated
R11857 T16178 T16179 advmod next,investigated
R11859 T16180 T16181 det the,requirement
R11860 T16181 T16179 dobj requirement,investigated
R11861 T16182 T16181 prep for,requirement
R11862 T16183 T16185 amod specific,molecules
R11863 T16184 T16185 amod signaling,molecules
R11864 T16185 T16182 pobj molecules,for
R11865 T16186 T16185 prep in,molecules
R11866 T16187 T16189 det the,pathway
R11867 T16188 T16189 compound TLR,pathway
R11868 T16189 T16186 pobj pathway,in
R11869 T16190 T16192 nsubjpass that,required
R11870 T16191 T16192 auxpass are,required
R11871 T16192 T16185 relcl required,molecules
R11872 T16193 T16192 prep for,required
R11873 T16194 T16195 compound MTb,stimulation
R11874 T16195 T16193 pobj stimulation,for
R11875 T16196 T16195 prep of,stimulation
R11876 T16197 T16199 nummod NFAT5,expression
R11877 T16198 T16199 compound gene,expression
R11878 T16199 T16196 pobj expression,of
R11879 T16200 T16179 punct .,investigated
R11880 T16201 T16202 nsubj We,began
R11883 T16204 T16203 pcomp examining,by
R11884 T16205 T16206 det the,requirement
R11885 T16206 T16204 dobj requirement,examining
R11886 T16207 T16206 prep of,requirement
R11887 T16208 T16209 nummod TLR2,ligation
R11888 T16209 T16207 pobj ligation,of
R11890 T16211 T16210 pcomp enhancing,in

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T15962 831-841 Positive_regulation denotes augmenting
T15961 858-864 Regulation denotes effect
T15960 879-889 Gene_expression denotes expression
T15959 680-688 Positive_regulation denotes enhanced
T15958 868-878 Protein denotes NFAT5 gene
T15957 689-699 Protein denotes NFAT5 mRNA
T15956 464-473 Positive_regulation denotes increased
T15955 427-437 Protein denotes NFAT5 mRNA
T15954 315-324 Positive_regulation denotes enhancing
T15953 303-311 Binding denotes ligation
T15952 325-335 Protein denotes NFAT5 mRNA
T15951 298-302 Protein denotes TLR2
T15950 245-255 Gene_expression denotes expression
T15949 234-244 Protein denotes NFAT5 gene
T15948 181-184 Protein denotes TLR
T15947 56-61 Protein denotes NFAT5
R11698 T15949 T15950 themeOf NFAT5 gene,expression
R11699 T15951 T15953 themeOf TLR2,ligation
R11700 T15952 T15954 themeOf NFAT5 mRNA,enhancing
R11701 T15955 T15956 themeOf NFAT5 mRNA,increased
R11702 T15957 T15959 themeOf NFAT5 mRNA,enhanced
R11703 T15958 T15960 themeOf NFAT5 gene,expression
R11704 T15960 T15961 themeOf expression,effect
R11705 T15961 T15962 themeOf effect,augmenting

testone

Id Subject Object Predicate Lexical cue
T14600 680-688 Positive_regulation denotes enhanced
T14599 303-311 Binding denotes ligation
T14598 283-294 Positive_regulation denotes requirement
T14597 245-255 Gene_expression denotes expression
T14550 868-873 Protein denotes NFAT5
T14549 689-694 Protein denotes NFAT5
T14548 427-432 Protein denotes NFAT5
T14547 383-387 Protein denotes TLR2
T14546 325-330 Protein denotes NFAT5
T14545 298-302 Protein denotes TLR2
T14544 234-239 Protein denotes NFAT5
T14543 56-61 Protein denotes NFAT5
R10812 T14544 T14597 themeOf NFAT5,expression
R10813 T14545 T14599 themeOf TLR2,ligation
R10814 T14549 T14600 themeOf NFAT5,enhanced
R10840 T14599 T14598 themeOf ligation,requirement

test3

Id Subject Object Predicate Lexical cue
T14696 868-873 Protein denotes NFAT5
T14695 689-694 Protein denotes NFAT5
T14694 464-473 Positive_regulation denotes increased
T14693 427-432 Protein denotes NFAT5
T14692 383-387 Protein denotes TLR2
T14691 325-330 Protein denotes NFAT5
T14690 303-311 Binding denotes ligation
T14689 298-302 Protein denotes TLR2
T14688 234-239 Protein denotes NFAT5
T14687 56-61 Protein denotes NFAT5
T14639 868-873 Protein denotes NFAT5
T14638 689-694 Protein denotes NFAT5
T14637 427-432 Protein denotes NFAT5
T14636 383-387 Protein denotes TLR2
T14635 325-330 Protein denotes NFAT5
T14634 298-302 Protein denotes TLR2
T14633 234-239 Protein denotes NFAT5
T14632 56-61 Protein denotes NFAT5
R10853 T14689 T14690 themeOf TLR2,ligation
R10854 T14693 T14694 themeOf NFAT5,increased